Old Web
English
Sign In
Acemap
>
authorDetail
>
Kevin Meyer
Kevin Meyer
University of Illinois at Chicago
Microbiology
Vancomycin
Oritavancin
Biology
Ceftazidime/avibactam
5
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of oritavancin alone and in combination against vancomycin-susceptible and resistant enterococci in an in vivo Galleria mellonella survival model
2019
International Journal of Antimicrobial Agents
Kevin Meyer
Matthew F. Deraedt
Amanda T. Harrington
Larry H. Danziger
Eric Wenzler
Show All
Source
Cite
Save
Citations (4)
Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms
2019
Journal of Antimicrobial Chemotherapy
Eric Wenzler
M Lee
T. Wu
Kevin Meyer
Ryan K. Shields
M.H. Nguyen
Cornelius J. Clancy
Romney M. Humphries
Amanda T. Harrington
Show All
Source
Cite
Save
Citations (5)
In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci
2019
Journal of Antimicrobial Chemotherapy
T. Wu
Kevin Meyer
Amanda T. Harrington
Larry H. Danziger
Eric Wenzler
Show All
Source
Cite
Save
Citations (7)
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water
2017
Hospital Pharmacy
Kevin Meyer
Maressa Santarossa
Larry H. Danziger
Eric Wenzler
Show All
Source
Cite
Save
Citations (5)
Efficacy of oritavancin and comparator agents against vancomycin-resistant Enterococcus faecium in an in vivo Galleria mellonella survival model
2016
Open Forum Infectious Diseases
Eric Wenzler
Matthew F. Deraedt
Kevin Meyer
Amanda T. Harrington
Larry H. Danziger
Show All
Source
Cite
Save
Citations (0)
1